🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Prevalence of Distal Symmetrical Polyneuropathy by Diabetes Prevention Program Treatment Group, Diabetes Status, Duration of Diabetes, and Cumulative Glycemic Exposure

Diabetes Care(2024)10.2337/dc23-2009Source: DataRank Database

Prevalence of Distal Symmetrical Polyneuropathy by Diabetes Prevention Program Treatment Group, Diabetes Status, Duration of Diabetes, and Cumulative Glycemic Exposure is a research paper published in Diabetes Care (2024). On theSindex it has a DataRank of 0. It has been cited 10 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access10 citations

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (26 grants)Impact (FWCI 2.45)OA: bronzeTopics (30)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (98)

Adam Ciarleglio ORCID,Sharon L. Edelstein ORCID,Jill P. Crandall ORCID,Dana Dabelea ORCID,Ronald Goldberg ORCID

Live enrichment

PubMed:38502874 PMC:PMC11043227 OpenAlex:https://openalex.org/W4392938827

National Institute of Diabetes and Digestive and Kidney Diseases

Grant: U01 DK048339

National Institute of Diabetes and Digestive and Kidney Diseases

Grant: U01 DK048349

National Institute of Diabetes and Digestive and Kidney Diseases

Grant: U01 DK048375

National Institute of Diabetes and Digestive and Kidney Diseases

Grant: U01 DK048377

National Institute of Diabetes and Digestive and Kidney Diseases

Grant: U01 DK048380

National Institute of Diabetes and Digestive and Kidney Diseases

Grant: U01 DK048381

National Institute of Diabetes and Digestive and Kidney Diseases

Grant: U01 DK048387

National Institute of Diabetes and Digestive and Kidney Diseases

Grant: U01 DK048397

National Institute of Diabetes and Digestive and Kidney Diseases

Grant: U01 DK048400

National Institute of Diabetes and Digestive and Kidney Diseases

Grant: U01 DK048404

National Institute of Diabetes and Digestive and Kidney Diseases

Grant: U01 DK048406

National Institute of Diabetes and Digestive and Kidney Diseases

Grant: U01 DK048407

National Institute of Diabetes and Digestive and Kidney Diseases

Grant: U01 DK048411

National Institute of Diabetes and Digestive and Kidney Diseases

Grant: U01 DK048412

National Institute of Diabetes and Digestive and Kidney Diseases

Grant: U01 DK048413

National Institute of Diabetes and Digestive and Kidney Diseases

Grant: U01 DK048434

National Institute of Diabetes and Digestive and Kidney Diseases

Grant: U01 DK048437

National Institute of Diabetes and Digestive and Kidney Diseases

Grant: U01 DK048443

National Institute of Diabetes and Digestive and Kidney Diseases

Grant: U01 DK048468

National Institute of Diabetes and Digestive and Kidney Diseases

Grant: U01 DK048485

National Institute of Diabetes and Digestive and Kidney Diseases

Grant: U01 DK048489

National Institute of Diabetes and Digestive and Kidney Diseases

Grant: U01 DK048514

NIDDK NIH HHS

Grant: P30 DK036836

NIDDK NIH HHS

Grant: P30 DK092926

NIDDK NIH HHS

Grant: P30 DK020572

NIDDK NIH HHS

Grant: P30 DK111022

FWCI

2.45

Citation Percentile

0.9%

Citation Trend

2025

2026

bronzeLicense: https://www.diabetesjournals.org/journals/pages/license

journalhttps://diabetesjournals.org/care/article-pdf/doi/10.2337/dc23-2009/750392/dc232009.pdf

publisherhttps://diabetesjournals.org/care/article-pdf/doi/10.2337/dc23-2009/750392/dc232009.pdf

publisherhttps://diabetesjournals.org/care/article-pdf/47/5/810/757741/dc232009.pdf

journalhttps://doi.org/10.2337/dc23-2009

repositoryhttps://pubmed.ncbi.nlm.nih.gov/38502874

Fields of Study

Pain Mechanisms and TreatmentsPeripheral Neuropathies and DisordersDiabetic Foot Ulcer Assessment and ManagementHumansAgedAdultHypoglycemic AgentsDiabetes Mellitus, Type 2PrevalenceMetforminPolyneuropathies

MeSH Terms

AdultAgedDiabetes Mellitus, Type 2HumansHypoglycemic AgentsMetforminPolyneuropathiesPrevalence

Keywords

MedicineDiabetes mellitusGlycemicMetforminPlaceboInternal medicineOdds ratioRandomizationRandomized controlled trialEndocrinologyPathology

Sustainable Development Goals

SDG 0: Good health and well-being

Related Papers (5)

Metformin-Induced Mitochondrial Complex I Inhibition: Facts, Uncertainties, and Consequences

Frontiers in Endocrinology(2018)

OpenAlex related

10.3389/fendo.2018.00753

Does a Placebo Run-In or a Placebo Treatment Cell Affect the Efficacy of Antidepressant Medications?

Neuropsychopharmacology(1994)

OpenAlex related

10.1038/npp.1994.63

Metformin for Prevention of Type 2 Diabetes

Annals of Pharmacotherapy(2004)

OpenAlex related

10.1345/aph.1d537

General Study on Metformin

Research Journal of Science and Technology(2023)

OpenAlex related

10.52711/2349-2988.2023.00005

Metformin as secondary therapy in a defined population with type 2 diabetes

Clinical Therapeutics(1999)

OpenAlex related

10.1016/s0149-2918(99)80047-2